The FDA’s long-awaited approval of Addyi, a drug promising to recharge waning sex drive in some women, has led to happy-dance sightings, grouchy doomsayer warnings about side effects and the usual misinformation about the act in general.
GAIL ROSENBLUM, Minneapolis Star Tribune
Sun, 08/30/2015 - 5:54am
The FDA’s long-awaited approval of Addyi, a drug promising to recharge waning sex drive in some women, has led to happy-dance sightings, grouchy doomsayer warnings about side effects and the usual misinformation about the act in general.